K, A., R, L., S, M., V, H., M, L., PH, G., & N, S. (2025). Soluble RAGE further stratifies risk of coronary artery and end-stage kidney disease in high-risk individuals with type 1 diabetes and treatment-resistant hypertension. Cardiovascular diabetology, 25(1), 13. https://doi.org/10.1186/s12933-025-03017-8
Chicago Style (17th ed.) CitationK, Adeshara, Lithovius R, Mutter S, Harjutsalo V, Lehto M, Groop PH, and Sandholm N. "Soluble RAGE Further Stratifies Risk of Coronary Artery and End-stage Kidney Disease in High-risk Individuals with Type 1 Diabetes and Treatment-resistant Hypertension." Cardiovascular Diabetology 25, no. 1 (2025): 13. https://doi.org/10.1186/s12933-025-03017-8.
MLA (9th ed.) CitationK, Adeshara, et al. "Soluble RAGE Further Stratifies Risk of Coronary Artery and End-stage Kidney Disease in High-risk Individuals with Type 1 Diabetes and Treatment-resistant Hypertension." Cardiovascular Diabetology, vol. 25, no. 1, 2025, p. 13, https://doi.org/10.1186/s12933-025-03017-8.